These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of phenytoin on dental caries and plaque in Streptococcus sobrinus-infected rats. Morisaki I; Loyola-Rodríguez JP; Adachi C; Hamada S Pediatr Dent; 1992; 14(5):322-5. PubMed ID: 1303536 [TBL] [Abstract][Full Text] [Related]
3. Gingival overgrowth induced by cyclosporin A in rats. Kitamura K; Morisaki I; Adachi C; Kato K; Mihara J; Sobue S; Hamada S Arch Oral Biol; 1990; 35(6):483-6. PubMed ID: 2372253 [TBL] [Abstract][Full Text] [Related]
4. [Cyclosporin-A induced gingival overgrowth--strain differences in the rats]. Adachi C; Kitamura K; Kato K; Yoshida M; Morisaki I; Sobue S Shoni Shikagaku Zasshi; 1991; 29(1):24-31. PubMed ID: 1838422 [TBL] [Abstract][Full Text] [Related]
5. Nifedipine-induced gingival overgrowth in the presence or absence of gingival inflammation in rats. Morisaki I; Kato K; Loyola-Rodriguez JP; Nagata T; Ishida H J Periodontal Res; 1993 Nov; 28(6 Pt 1):396-403. PubMed ID: 8254456 [TBL] [Abstract][Full Text] [Related]
6. Incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients in general medical practice. Thomason JM; Seymour RA; Rawlins MD Community Dent Oral Epidemiol; 1992 Oct; 20(5):288-91. PubMed ID: 1424550 [TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model. Nishikawa S; Nagata T; Morisaki I; Oka T; Ishida H J Periodontol; 1996 May; 67(5):463-71. PubMed ID: 8724703 [TBL] [Abstract][Full Text] [Related]
8. Microbial flora and clinical parameters in phenytoin associated gingival overgrowth. Smith QT; Wilson MM; Germaine GR; Pihlstrom BL J Periodontal Res; 1983 Jan; 18(1):56-66. PubMed ID: 6222175 [No Abstract] [Full Text] [Related]
9. The effect of a plaque control program on the development of phenytoin-induced gingival overgrowth. A 2-year longitudinal study. Dahllöf G; Modéer T J Clin Periodontol; 1986 Oct; 13(9):845-9. PubMed ID: 3465754 [TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of phenytoin in gingival crevicular fluid and plasma in relation to gingival overgrowth. McLaughlin WS; Ball DE; Seymour RA; Kamali F; White K J Clin Periodontol; 1995 Dec; 22(12):942-5. PubMed ID: 8613563 [TBL] [Abstract][Full Text] [Related]
11. Plasma and saliva concentrations of phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in relation to the incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients. Ball DE; McLaughlin WS; Seymour RA; Kamali F J Periodontol; 1996 Jun; 67(6):597-602. PubMed ID: 8794970 [TBL] [Abstract][Full Text] [Related]
12. Phenytoin and 5-(p-hydroxyphenyl)-5-phenylhydantoin do not alter the effects of bacterial and amplified plaque extracts on cultures of fibroblasts from normal and overgrown gingivae. Smith QT; Hinrichs JE J Dent Res; 1987 Aug; 66(8):1393-8. PubMed ID: 3476609 [TBL] [Abstract][Full Text] [Related]
13. Development of phenytoin-induced gingival overgrowth in non-institutionalized epileptic children subjected to different plaque control programs. Modéer T; Dahllöf G Acta Odontol Scand; 1987 Apr; 45(2):81-5. PubMed ID: 2955633 [TBL] [Abstract][Full Text] [Related]